News
Solara Active Pharma Sciences reports consolidated net profit of Rs 9.60 crore in the March 2026 quarter
15-May-2026 | 14:32
Sales rise 41.86% to Rs 387.29 crore
Net profit of Solara Active Pharma Sciences reported to Rs 9.60 crore in the quarter ended March 2026 as against net loss of Rs 2.10 crore during the previous quarter ended March 2025. Sales rose 41.86% to Rs 387.29 crore in the quarter ended March 2026 as against Rs 273.01 crore during the previous quarter ended March 2025.
For the full year,net loss reported to Rs 7.41 crore in the year ended March 2026 as against net profit of Rs 0.54 crore during the previous year ended March 2025. Sales rose 6.64% to Rs 1368.98 crore in the year ended March 2026 as against Rs 1283.76 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 387.29 | 273.01 | 42 | 1368.98 | 1283.76 | 7 |
| OPM % | 14.89 | 16.62 | - | 13.64 | 16.07 | - |
| PBDT | 34.78 | 22.20 | 57 | 98.16 | 99.79 | -2 |
| PBT | 8.74 | -2.10 | LP | -1.52 | 0.54 | PL |
| NP | 9.60 | -2.10 | LP | -7.41 | 0.54 | PL |
Powered by Capital Market - Live News
